A Simple Key For ABBV-744 BRD4 inhibition in cancer cell lines Unveiled
The existing work examined the potential of utilizing ARV-825 and ABBV-744 to raise the effectiveness of tamoxifen or fulvestrant in addition palbociclib. ARV-825 was effective in both of those p53 wild-sort (WT) breast tumor cells and in cells lacking useful p53 possibly by itself or in combination with tamoxifen, whilst the effectiveness of ABBV-